Surface-expressed GRP78 was discovered to boost the generation of diverse cytokines with anti-tumor properties, including interferon (IFN)-γ, interleukin (IL)-2, tumor necrosis factor α (TNFα), and granulocyte–macrophage colony-stimulating factor (GM-CSF). Here, IL2 is linked to neoplasm.